MedTrace Logo

Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function

NCT00444106 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 265

Last updated 2011-04-05

Study results available
· View outcomes & findings →

Summary

To evaluate the potential effects of artemether- lumefantrine on the auditory function

Conditions

Interventions

DRUG

Artesunate-mefloquine

DRUG

Atovaquone-proguanil

DRUG

Artemether-lumefantrine

Sponsors & Collaborators

Principal Investigators

  • Novartis · Novartis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00444106 on ClinicalTrials.gov